- Home
- CMMB vs CCM Comparison
CMMB vs CCM Comparison
Compare CMMB & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMMB | CCM |
|---|---|---|
| Founded | 2004 | 1997 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.5M | 21.3M |
| IPO Year | 2023 | 2009 |
Fundamental Metrics
Financial Performance| Metric | CMMB | CCM |
|---|---|---|
| Price | $1.31 | $3.38 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 117.2K | 11.3K |
| Earning Date | 11-19-2026 | 10-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $40.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.35 | $3.18 |
| 52 Week High | $3.55 | $6.96 |
Technical Indicators
Market Signals| Indicator | CMMB | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 25.39 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $1.83 | N/A |
| Average True Range (ATR) | 0.27 | 0.00 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 13.07 | 0.00 |
Price Performance
Historical ComparisonAbout CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.